Emergence and spread of three clonally related virulent isolates of CTX-M-15-producing Escherichia coli with variable resistance to aminoglycosides and tetracycline in a French geriatric hospital

被引:107
作者
Leflon-Guibout, V
Jurand, C
Bonacorsi, S
Espinasse, F
Guelfi, MC
Duportail, F
Heym, B
Bingen, E
Nicolas-Chanoine, MH
机构
[1] Hop Ambroise Pare, Serv Microbiol Hyg, F-92100 Boulogne, France
[2] Hop Ambroise Pare, Dept Hyg, F-92100 Boulogne, France
[3] Univ St Quentin en Yvelines, Fac Med Paris Ile France Ouest, Versailles, France
[4] Hop Robert Debre, Microbiol Serv, F-75019 Paris, France
[5] Hop St Perine Chardon Lagache, Dept Med Informat, Paris, France
关键词
D O I
10.1128/AAC.48.10.3736-3742.2004
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Three types of multidrug-resistant Escherichia coli isolates, called GEN S, GEN R, and AMG S, according to their three different aminoglycoside resistance patterns, were responsible for urinary tract colonization or infection in 87, 12, and 13 new patients, respectively, in a French 650-bed geriatric hospital over a 13-month period. The three E. coli types belonged to the same clone and phylogenetic group (group 132) and had identical transferable plasmid contents (a 120-kb plasmid), beta-lactam and fluoroquinolone resistance genotypes bla(TEM.1B), bla(CTX-M-15), and double mutations in both the gyrA and the parC genes), and virulence factor genotypes (aer ,fyu,49 and irp2). They disseminated in the geriatric hospital, where the antibiotics prescribed most often were fluoroquinolones and ceftriaxone, but not in the affiliated acute-care hospital, where isolation precautions were applied to the transferred patients. Thus, E. coli isolates, both CTX-M-type beta-lactamase producers and fluoroquinolone-resistant isolates, might present a new challenge for French health care settings.
引用
收藏
页码:3736 / 3742
页数:7
相关论文
共 44 条
  • [1] Imipenem resistance in Salmonella enterica serovar Wien related to porin loss and CMY-4 β-lactamase production
    Armand-Lefèvre, L
    Leflon-Guibout, V
    Bredin, J
    Barguellil, F
    Amor, A
    Pagès, JM
    Nicolas-Chanoine, MH
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (03) : 1165 - 1168
  • [2] Ceftazidime-hydrolysing CTX-M-15 extended-spectrum β-lactamase (ESBL) in Poland
    Baraniak, A
    Fiett, J
    Hryniewicz, W
    Nordmann, P
    Gniadkowski, M
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2002, 50 (03) : 393 - 396
  • [3] CLOSE AMINO-ACID-SEQUENCE RELATIONSHIP BETWEEN THE NEW PLASMID-MEDIATED EXTENDED-SPECTRUM BETA-LACTAMASE-BULLET-MEN-1 AND CHROMOSOMALLY ENCODED ENZYMES OF KLEBSIELLA-OXYTOCA
    BARTHELEMY, M
    PEDUZZI, J
    BERNARD, H
    TANCREDE, C
    LABIA, R
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA, 1992, 1122 (01) : 15 - 22
  • [4] Phylogenetic analysis of Escherichia coli strains causing neonatal meningitis suggests horizontal gene transfer from a predominant pool of highly virulent B2 group strains
    Bingen, E
    Picard, B
    Brahimi, N
    Mathy, S
    Desjardins, P
    Elion, J
    Denamur, E
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1998, 177 (03) : 642 - 650
  • [5] Phylogenetic analysis and prevalence of urosepsis strains of Escherichia coli bearing pathogenicity island-like domains
    Bingen-Bidois, M
    Clermont, O
    Bonacorsi, S
    Terki, M
    Brahimi, N
    Loukil, C
    Barraud, D
    Bingen, E
    [J]. INFECTION AND IMMUNITY, 2002, 70 (06) : 3216 - 3226
  • [6] Growing group of extended-spectrum β-lactamases:: The CTX-M enzymes
    Bonnet, R
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (01) : 1 - 14
  • [7] Identification and broad dissemination of the CTX-M-14 β-lactamase in different Escherichia coli strains in the northwest area of Spain
    Bou, G
    Cartelle, M
    Tomas, M
    Canle, D
    Molina, F
    Moure, R
    Eiros, JM
    Guerrero, A
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2002, 40 (11) : 4030 - 4036
  • [8] 2003 report by the members of the French Society of Microbiology Antiobiogram Committee
    Carret, G
    Cavallo, JD
    Chardon, H
    Chidiac, C
    Choutet, P
    Courvalin, P
    Dabernat, H
    Drugeon, H
    Dubreuil, L
    Goldstein, F
    Jarlier, V
    Leclercq, R
    Nicholas-Chanoine, MH
    Philippon, A
    Quentin-Noury, C
    Rouveix, B
    Sirot, J
    Soussy, CJ
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2003, 21 (04) : 364 - 391
  • [9] Molecular epidemiology and mutations at gyrA and parC genes of ciprofloxacin-resistant Escherichia coli isolates from a Taiwan Medical Center
    Chen, JY
    Siu, LK
    Chen, YH
    Lu, PL
    Ho, M
    Peng, CF
    [J]. MICROBIAL DRUG RESISTANCE-MECHANISMS EPIDEMIOLOGY AND DISEASE, 2001, 7 (01): : 47 - 53
  • [10] Rapid and simple determination of the Escherichia coli phylogenetic group
    Clermont, O
    Bonacorsi, S
    Bingen, E
    [J]. APPLIED AND ENVIRONMENTAL MICROBIOLOGY, 2000, 66 (10) : 4555 - 4558